Colombia is a modern, hybrid-indica cultivar developed through a genetic lineage that combines Mostly Indica, Hassala, and Afghanistan-Indica. This plant reaches maturity after a 60-day flowering period, consistently delivering high yields for cultivators of moderate experience who manage environments both indoors and outdoors. Within the broader genetic landscape, this strain is recognized for its role in the development of offspring such as Hassala and Schrom.

The terpene profile of Colombia is led by terpinolene, followed closely by myrcene and pinene, creating a nuanced aromatic complexity. The array of secondary and tertiary compounds includes limonene, caryophyllene, and ocimene, with traces of beta-pinene, humulene, and linalool. The profile is finished with bisabolol, guaiol, alpha-terpinene, nerolidol, and gamma-terpinene, which collectively contribute to the chemical character of this THC-dominant strain.

Users of Colombia report effects characterized by a sense of relaxation, calmness, and mental focus. These qualities make the strain a functional choice for those managing pain, stress, or difficulties with sleep. By balancing these therapeutic use cases with its notable record as a parent to other significant cultivars, Colombia maintains its standing as a versatile hybrid-indica within the modern cannabis market.